What Pharmaceutical GMP Audit Services Cover
Pharmaceutical GMP audit services are designed specifically for the drug manufacturing sector. The work covers finished dosage forms, active pharmaceutical ingredients, and the contract organizations that support them. Audits examine whether the operation meets the full set of pharmaceutical GMP requirements across production, quality control, documentation, and facility management.
What makes pharmaceutical auditing different from general manufacturing audits is the level of detail regulators expect. A batch record must show exactly who did what and when. An investigation must reach a defensible root cause. A validation package must support the process it describes. Our audits are built around these expectations.
The Regulatory Framework Behind Pharmaceutical GMP Audits
FDA 21 CFR Parts 210 and 211
These regulations set the cGMP requirements for finished pharmaceuticals in the United States. They cover organization and personnel, buildings and facilities, equipment, control of components, production and process controls, packaging and labeling, holding and distribution, laboratory controls, and records and reports. Every audit we perform maps back to these requirements.
EU GMP Guide, EudraLex Volume 4
The EU GMP Guide covers medicinal products in Part I, APIs in Part II, and a long list of annexes for specific dosage forms and topics. The 2022 revision of Annex 1, which deals with sterile products, introduced significant new expectations around contamination control. We audit against all relevant parts and annexes.
ICH Q7 for APIs
ICH Q7 sets GMP requirements for active pharmaceutical ingredients. It covers everything from quality management to specific production and laboratory controls for API manufacturing.
ICH Q9 and Q10
Quality risk management and the pharmaceutical quality system are cross cutting expectations that apply to every pharmaceutical manufacturer. Our audits check how well these are embedded in daily practice.
What Our Pharmaceutical GMP Audits Evaluate
Batch Records and Documentation
We review batch records for completeness, accuracy, and traceability. We look at whether deviations were documented and investigated, and whether the records tell a coherent story from start to finish.
Validation and Qualification Status
We check the status of process validation, cleaning validation, analytical method validation, and equipment qualification. We look for gaps between what was planned and what was actually done.
Environmental Monitoring and Contamination Control
For sterile and non sterile products alike, contamination control matters. We review environmental monitoring data, trend analysis, and the overall contamination control strategy.
Laboratory Controls and Data Integrity
Laboratory data must be reliable. We review analytical methods, instrument qualification, and data integrity controls such as audit trails, user access, and electronic record management.
Supplier and CMO Oversight
Most pharmaceutical companies rely on suppliers and contract manufacturers. We check whether oversight is real and documented, not just a folder of certificates.
Annex 1 Readiness for Sterile Manufacturing
The revised Annex 1 requires a holistic contamination control strategy, not just a set of individual controls. We audit against the full set of expectations, including aseptic process simulation, gowning qualification, and the requirement for pre use post sterilization integrity testing where applicable. Companies facing EU inspections for sterile products should treat this as a priority.
Request a Pharmaceutical GMP Audit
Learn more at https://www.gxpcellators.com/gmp-auditing/. Contact us at or through https://www.gxpcellators.com/contact/ to discuss your product types and audit scope.
Frequently Asked Questions About Pharmaceutical GMP Audit Services
Do you audit both sterile and non sterile products?
Yes. Sterile products bring additional requirements, especially under EU Annex 1, and we audit against those. Non sterile solid and liquid dosage forms are also within our scope.
Can you audit our contract manufacturer on our behalf?
Yes. We regularly audit CMOs on behalf of the contract giver. You receive the report, and we can help you evaluate the CMO’s corrective actions.
How do you handle API audits under ICH Q7?
We review the full ICH Q7 scope, including quality management, personnel, facilities, process equipment, documentation, materials management, production, packaging, laboratory controls, and stability. Supplier and contractor oversight is also covered.
What if we are preparing for an EU inspection for sterile products?
We recommend a focused Annex 1 readiness audit. It covers the contamination control strategy, aseptic process simulation, gowning, and integrity testing expectations.
Do you review data integrity as part of pharmaceutical audits?
Yes. Data integrity is a standard part of every audit. We review audit trails, user access controls, and how electronic records are managed and retained.
How do you keep the audit focused on our products?
Before the audit we review your product types, processes, and markets. The audit plan is built around those specifics, not a generic checklist.
How can I request a pharmaceutical GMP audit?
Email or use https://www.gxpcellators.com/contact/. Our services are described at https://www.gxpcellators.com/gmp-auditing/.
